Cancer Causes & Control

, Volume 11, Issue 6, pp 565–576 | Cite as

The cancer-preventive potential of Panax ginseng: a review of human and experimental evidence

  • Hai Rim Shin
  • Joon Youn Kim
  • Taik Koo Yun
  • Gareth Morgan
  • Harri Vainio


Objective: We have reviewed the potential cancer-preventive and other relevant properties of Panax ginseng C. A. Meyer, which has been traditionally used as a natural tonic in Oriental countries.

Data identification and study selection: Publications on Panax ginseng and its relation to cancer were obtained from the Medline database (1983–1998) and by checking reference lists to find earlier reports. The reports cover experimental models and human studies on cancer-preventive activity, carcinogenicity and other beneficial or adverse effects. In addition, possible mechanisms of chemoprevention by ginseng were considered.

Results: Published results from a cohort and two case–control studies in Korea suggest that the intake of ginseng may reduce the risk of several types of cancer. When ginseng was tested in animal models, a reduction in cancer incidence and multiplicity at various sites was noted. Panax ginseng and its chemical constituents have been tested for their inhibiting effect on putative carcinogenesis mechanisms (e.g., cell proliferation and apoptosis, immunosurveillance, angiogenesis); in most experiments inhibitory effects were found.

Conclusion: While Panax ginseng C. A. Meyer has shown cancer-preventive effects both in experimental models and in epidemiological studies, the evidence is currently not conclusive as to its cancer-preventive activity in humans. The available evidence warrants further research into the possible role of ginseng in the prevention of human cancer and carcinogenesis.

cancer-preventive activity experimental models ginseng mechanisms of anti-carcinogenesis 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Wen J, Zimmer EA (1996) Phylogeny and biogeography of Panax L. (the ginseng genus, Araliaceae): inferences from ITS sequences of nuclear ribosomal DNA. In: Molecular Phylogenetics and Evolution 6: 167–177.Google Scholar
  2. 2.
    Tanaka O, Kasai R, Norita T (1986) Chemistry of ginseng and related plants. Rec Adv Abstr Chinese Med 1: 130–152.Google Scholar
  3. 3.
    Hu SY (1976) The genus Panax (ginseng) in Chinese medicine. Econ Bot 30: 11–28.Google Scholar
  4. 4.
    Liu CX, Xiao PG (1992) Recent advances on ginseng research in China. J Ethnopharmacol 36: 27–38.Google Scholar
  5. 5.
    Cui J, Garle P, Bjorkhem I (1994) What do commercial ginseng preparations contain? Lancet 344: 134.Google Scholar
  6. 6.
    Siegel RK (1979) Ginseng abuse syndrome. Problems with the panacea. JAMA 241: 1614–1615.Google Scholar
  7. 7.
    Park JD (1996) Recent studies on the chemical constituents of Korean ginseng (Panax ginseng C. A. Meyer). Korean J Ginseng Sci 20: 389–415.Google Scholar
  8. 8.
    Yun TK, Choi SY, Lee YS, eds (1997) Nontoxic and Nonorgan Specific Cancer Preventive Effect of Panax ginseng C. A. Meyer. In Shibamoto T, Tirao J, Osawa T, eds. ACS Symposium series 702: Functional foods for disease prevention II, Medicinal plants and other foods. California: 162–177.Google Scholar
  9. 9.
    Scaglione F, Cogo R, Cucuzza C, Arcidacono M, Beretta A (1994) Immunomodulatory effects of Panax ginseng C. A. Meyer (G115) on alveolar macrophages from patients suffering with chronic bronchitis. Int J Immunother 10: 21–24.Google Scholar
  10. 10.
    Zhang GD, Zhou ZH, Wang MZ, Gao FY (1980) Analysis of ginseng. II. Acta Pharm Sinica 15: 175–181.Google Scholar
  11. 11.
    Xu SX, Wang NL, Shen M, Lu XK (1986) Studies on the chemical constituents of saponins of the stems and leaves of Panax ginseng C. A. Meyer. Acta Bot Sinica 28: 95–101.Google Scholar
  12. 12.
    Zhang GD, Zhou ZH, Gao FY (1979) Analysis of ginseng. I. Acta Pharm Sinica 14: 309–314.Google Scholar
  13. 13.
    Yun TK, Yun YS, Han IW (1980) An experimental study on tumor inhibitory effect of red ginseng in mice and rats exposed to various chemical carcinogens. In: 3rd International Ginseng Symposium; 1980; Seoul: Korea Ginseng Research Institute Press, pp. 87–113.Google Scholar
  14. 14.
    Yun TK, Yun YS, Han IW (1983) Anticarcinogenic effect of long-term oral administration of red ginseng on newborn mice exposed to various chemical carcinogens. Cancer Detect Prev 6: 515–525.Google Scholar
  15. 15.
    Yun TK, Kim SH, Oh YR (1987) Medium-term (nine week) method for assay of preventive agents against tumors. J Korean Cancer Res 19: 1–7.Google Scholar
  16. 16.
    Yun TK, Kim SH (1988) Inhibition of development of benzo(a)pyrene-induced mouse pulmonary adenoma by natural products medium-term bioassay system. J Korean Cancer Assoc 20: 133–142.Google Scholar
  17. 17.
    Yun TK, Kim SH, Lee YS (1995) Trial of a new medium-term model using benz(a)pyrene induced lung tumor in newborn mice. Anticancer Res 15: 839–846.Google Scholar
  18. 18.
    Yun TK (1996) Experimental and epidemiological evidence of the cancer-preventive effects of Panax ginseng C. A. Meyer. Nutr Rev 54: S71–S81.Google Scholar
  19. 19.
    Yun TK, Lee YS (1994) Anticarcinogenic effect of ginseng powders depending on the types and ages using Yun's anticarcinogenicity test (I). Korean J Ginseng Sci 18: 89–94.Google Scholar
  20. 20.
    Yun TK, Lee YS (1994) Anticarcinogenic effect of ginseng powders depending on the types and ages using Yun's anticarcinogenicity test (II). Korean J Ginseng Sci 18: 160–164.Google Scholar
  21. 21.
    Lee YS, Chung IS, Lee IR, Kim KH, Hong WS, Yun YS (1997) Activation of multiple effector pathway of immune system by the antineoplastic immunostimulator acidic polysaccharide ginsan isolated from Panax ginseng. Anticancer Res 17: 323–332.Google Scholar
  22. 22.
    You M, Bergman G (1998) Preclinical and clinical models of lung cancer chemoprevention. Hematol/Oncol Clin N Am 12: 1037–1053.Google Scholar
  23. 23.
    Wu XG, Zhu DH (1990) Influence of ginseng upon the development of liver cancer induced by diethylnitrosamine in rats. J Tongji Med Univ 10: 141–145.Google Scholar
  24. 24.
    Li X, Wu XG (1991) Effects of ginseng on hepatocellular carcinoma in rats induced by diethylnitrosamine-a further study. J Tongji Med Univ 11: 72–80.Google Scholar
  25. 25.
    Kim JP, Park JG, Lee MD, et al. (1985) Co-carcinogenic effects of several Korean foods on gastric cancer induced by N-methyl-N′-nitro-N-nitrosoguanidine in rats. Jpn J Surg 15: 427–437.Google Scholar
  26. 26.
    Nagata H, Kikuchi Y, Tode T, et al. (1998) Inhibitory effects of ginsenoside Rh2 on tumor growth in nude mice bearing human ovarian cancer cells. Jpn J Cancer Res 89: 733–740.Google Scholar
  27. 27.
    Kikuchi Y, Sasa H, Kita T, Hirata J, Tode T, Nagata I (1991) Inhibition of human ovarian cancer cell proliferation in vitro by ginsenoside Rh2 and adjuvant effects to cisplatin in vivo. Anti-cancer Drugs 2: 63–67.Google Scholar
  28. 28.
    Tode T, Kikuchi Y, Kita T, Hirata J, Imaizumi E, Nagata I (1993) Inhibitory effects by oral administration of ginsenoside Rh2 on the growth of human ovarian cancer cells in nude mice. J Cancer Res Clin Oncol 120: 24–26.Google Scholar
  29. 29.
    Chen Xiaoguang, Liu Hongyan, Lei Xiaohong, et al. (1998) Cancer chemopreventive and therapeutic activities of red ginseng. J Ethnopharmacol 60: 71–78.Google Scholar
  30. 30.
    Bespalove VG, Davydov VV, Limarenko AY, Slenpyan LI, Aleksandrov VA (1993) Inhibition of the development of experimental uterus cervix and vaginal tumors by tinctures from biomasses of cultivated cells of ginseng and its germanium-selective stocks. Biull Eksp Biol Med 116: 534–536.Google Scholar
  31. 31.
    Bespalove VG, Alexandrov VA, Davydov VV, et al. (1993) Inhibition of mammary gland carcinogenesis using a tincture from biomass of ginseng tissue culture. Biull Eksp Biol Med 115: 59–61.Google Scholar
  32. 32.
    Yun TK, Choi SY (1990) A case-control study of ginseng intake and cancer. Int J Epidemiol 19: 871–876.Google Scholar
  33. 33.
    Yun TK, Choi SY (1995) Preventive effect of ginseng intake against various human cancers: a case-control study on 1987 pairs. Cancer Epidemiol Biomarkers Prev 4: 401–408.Google Scholar
  34. 34.
    Berg JW, Ross R, Latourette HB (1997) Economic status and survival of cancer patients. Cancer 39: 467–477.Google Scholar
  35. 35.
    Yun TK, Choi SY, Lee YS (1995) A prospective study on ginseng intake and cancer for population-Preliminary report. Korean J Ginseng Sci 19: 87–92.Google Scholar
  36. 36.
    Yun TK, Choi SY (1998) Non-organ specific cancer prevention of ginseng: a prospective study in Korea. Int J Epidemiol 27: 359–364.Google Scholar
  37. 37.
    Yeung HW, Cheung K, Leung KL (1982) Immunopharmacology of Chinese medicine. 1: Ginseng-induced immunosuppression in virus-infected mice. Am J Chinese Med X: 44–54.Google Scholar
  38. 38.
    Singh VK, Agarwal SS, Gupta BM (1984) Immunomodulatory activity of Panax ginseng extract. Planta Med 50: 462–465.Google Scholar
  39. 39.
    Jie YH, Cammisuli S, Baggiolini M (1984) Immunomodulatory effects of Panax ginseng C. A. Meyer in the mouse. Agents Actions 15: 386–391.Google Scholar
  40. 40.
    Yang GZ, Bao T, Geng PL (1986) The immunoregulatory effect of ginsenoside in vivo and in vitro. J Trad Chinese Med 6: 191–194.Google Scholar
  41. 41.
    Yang GZ, Yu YL (1988) Effects of ginsenoside on the natural killer cell-interferon-interlukin-2 regulatory network and its tumor inhibiting effect. J Trad Chinese Med 8: 135–140.Google Scholar
  42. 42.
    Yang GZ, Yu YL (1990) Immunopotentiating effect of traditional Chinese drugs-ginsenoside and glycyrrhiza polysaccharide. Proc CAMS PUMC 5: 188–193.Google Scholar
  43. 43.
    Yun YS, Jo SK, Moon HS, Kim YJ, Oh YR, Yun TK (1987) Effect of red ginseng on natural killer cell activity in mice with lung adenoma induced by urethane and benzo(a)pyrene. Cancer Detect Prev 26: 301–309.Google Scholar
  44. 44.
    Yun YS, Lee YS, Jo SK, Jung IS (1993) Inhibition of autochthonous tumor by ethanol insoluble fraction from Panax ginseng as an immunomodulator. Plant Med 59: 521–524.Google Scholar
  45. 45.
    Kenarova B, Neychev H, Hadjiivanova C, Petkov VD (1990) Immunomodulating activity of ginsenoside Rg1 from Panax ginseng. Jpn J Pharmacol 54: 447–454.Google Scholar
  46. 46.
    Mizuno M, Yamada J, Terai H, Kozukue N, Lee YS, Tsuchida H (1994) Differences in immunomodulation effects between wild and cultured Panax ginseng. Biochem Biophys Res Commun 200: 1672–1678.Google Scholar
  47. 47.
    Kim JY, Gemolec DR, Luster MI (1990) Panax ginseng as a potential immunomodulator: studies in mice. Immunopharmacol Immunotoxicol 12: 257–276.Google Scholar
  48. 48.
    Abdrasilov BS, Kim YA, Nurieva RI, et al. (1996) The effect of total saponins from Panax ginseng C. A. Meyer on the intracellular signaling system in Ehrlich ascites tumor cells. Biochem Molec Int 38: 519–526.Google Scholar
  49. 49.
    Park MK, Hwang WI (1996) Effects of the petroleum-ether extracts of ginseng on the cell cycle and protein kinase C activity in cancer cells. Korean J Ginseng Sci 20: 219–225.Google Scholar
  50. 50.
    Shin EK, Park HW, Kim SC, Jung NP (1996) The effects of ginseng components on the signal transduction in the activation of murine macrophages. Korean J Ginseng Sci 20: 159–167.Google Scholar
  51. 51.
    Fan ZH, Isobe L, Kiuchi K, Nakashima I. Enhancement of nitric oxide production from activated macrophages by a purified from of ginsenoside (Rg1). Am J Chinese Med 23: 279–287.Google Scholar
  52. 52.
    Kim YH, Park KH, Rho HM (1996) Transcriptional activation of the Cu, Zn-superoxide dismutase gene through the AP2 site by ginsenoside Rb2 extracted from a medicinal plant, Panax ginseng. J Biol Chem 271: 24539–24543.Google Scholar
  53. 53.
    Umnova NV, Michurina TL, Smironova NI, Aleksandrova IV, Poroshenko GG (1991) In vitro and in vivo studies of bioginseng antimutagen properties in mammalian cells. Biull Eksp Biol Med 111: 507–509.Google Scholar
  54. 54.
    Rhee TH, Ahn JH, Choe J, Kang KW, Joe C (1991) Inhibition of mutagenesis and transformation by root extracts of Panax ginseng in vitro. Planta Med 57: 125–128.Google Scholar
  55. 55.
    Sato K, Mochizuki M, Saiki I, Yoo YC, Samukawa K, Azuma I (1994) Inhibition of tumor angiogenesis and metastasis by a saponin of Panax ginseng, Ginsenoside-Rb2. Biol Pharmacol Bull 17: 635–639.Google Scholar
  56. 56.
    Mochizuki M, Yoo YC, Matsuzawa K, et al. (1995) Inhibitory effect of tumor metastasis in mice by saponins Ginsenoside-Rb2, 20(R)-and 20(S)-ginsenoside Rg3, of Red ginseng. Biol Pharm Bull 18: 1197–1202.Google Scholar
  57. 57.
    Shinkai K, Akedo H, Mukai M, et al. (1996) Inhibition of in vitro tumor cell invasion by ginsenoside Rg3. Jpn J Cancer Res 87: 357–362.Google Scholar
  58. 58.
    Palmer BV, Montgomery ACV, Monterio JCMP (1978) Ginseng and mastalgia [letter]. BMJ 1: 1284.Google Scholar
  59. 59.
    Punnone R, Lukola A (1978) Oestrogen like effect of ginseng [letter]. BMJ 1: 1284.Google Scholar
  60. 60.
    Greenspan EM (1983) Ginseng and vaginal bleeding [letter]. JAMA 249: 2018.Google Scholar
  61. 61.
    Hopkins MP, Andro. L, Beningsho. AS (1988) Ginseng face-cream and unexplained vaginal bleeding. Am J Obstet Gynecol 159: 1121–1122.Google Scholar
  62. 62.
    Korieh OM (1978) Ginseng and mastalgia [letter]. BMJ 1: 1284.Google Scholar
  63. 63.
    Albertsson M, Seiving B (1996) Adverse effect of ginseng: no cure in breast cancer. Läkartidninten 93: 2670–2672.Google Scholar
  64. 64.
    Ryu SJ, Chien YY (1995) Ginseng-associated cerebral arteritis. Neurology 45: 829–830.Google Scholar
  65. 65.
    Dega H, Larte JL, Frances C, Herson S, Chosidow O (1996) Ginseng as a cause for Stevens-Johnson syndrome? Lancet 347: 1344.Google Scholar
  66. 66.
    Faleni R, Soldati F (1996) Ginseng as cause of Stevens-Johnson syndrome? Lancet 348: 267.Google Scholar

Copyright information

© Kluwer Academic Publishers 2000

Authors and Affiliations

  • Hai Rim Shin
    • 1
  • Joon Youn Kim
    • 1
  • Taik Koo Yun
    • 2
  • Gareth Morgan
    • 3
  • Harri Vainio
    • 3
  1. 1.Department of Preventive Medicine, College of MedicineDong-A UniversityPusanKorea
  2. 2.Laboratory of Experimental Pathology, Korea Atomic Energy Research InstituteKorea Cancer Center HospitalSeoulKorea
  3. 3.Unit of ChemopreventionInternational Agency for Research on CancerLyonFrance

Personalised recommendations